» Articles » PMID: 10805362

Association of Lower Genital Tract Inflammation with Objective Evidence of Endometritis

Overview
Publisher Wiley
Date 2000 May 11
PMID 10805362
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this report is to evaluate the association between lower genital tract inflammation and objectively diagnosed endometritis. We analyzed the first 157 patients enrolled in the PEACH study, a multicenter randomized clinical trial designed to compare the effectiveness of outpatient and inpatient therapy for PID. Women less than 38 years of age, who presented with a history of pelvic discomfort for 30 days or less and who were found to have pelvic organ tenderness (uterine or adnexal tenderness) on bimanual examination, were initially invited to participate. After recruitment of the first 58 patients (group 1) we added the presence of leukorrhea, mucopurulent cervicitis, or untreated positive test for N. gonorrhoeae or C. trachomatis to the inclusion criteria (group 2, N = 99). We compared rates of endometritis in the two groups and calculated the sensitivity, specificity, and predicted values of the presence of white blood cells in the vaginal wet preparation. The rate of upper genital tract infection in group 1 was 46.5% (27/58) compared to 49.5% (49/99) in group 2. Microbiologic evidence of either N. gonorrhoeae or C. trachomatis increased from 22.4% in group 1 to 38.3% in group 2. The presence of vaginal white blood cells or mucopus has a high sensitivity (88.9%), but a low specificity (19.4%) for the diagnosis of upper genital-tract infection. Assessment of the lower genital tract for evidence of infection or inflammation is a valuable component of the diagnostic evaluation of pelvic inflammatory disease. The presence of either mucopus or vaginal white blood cells is a highly sensitive test for endometritis in patients with pelvic pain and tenderness.

Citing Articles

Exploration into the Mechanism of Yiyi Baijiang Decoction Attenuating Chronic Pelvic Inflammation Based on Network Pharmacology and Experimental Verification.

Wei Y, Su H, Li J, Zheng W, Li L, Zhou M Biochem Genet. 2024; .

PMID: 38856955 DOI: 10.1007/s10528-024-10843-0.


Patterns of within-host spread of between vagina, endocervix and rectum revealed by comparative genomic analysis.

Joseph S, Bommana S, Ziklo N, Kama M, Dean D, Read T Front Microbiol. 2023; 14:1154664.

PMID: 37056744 PMC: 10086254. DOI: 10.3389/fmicb.2023.1154664.


Citral protects against LPS-induced endometritis by inhibiting ferroptosis through activating Nrf2 signaling pathway.

Zhao W, Wang J, Li Y, Ye C Inflammopharmacology. 2023; 31(3):1551-1558.

PMID: 37010717 DOI: 10.1007/s10787-023-01211-2.


Patterns of within-host spread of between vagina, endocervix and rectum revealed by comparative genomic analysis.

Joseph S, Bommana S, Ziklo N, Kama M, Dean D, Read T bioRxiv. 2023; .

PMID: 36747780 PMC: 9901013. DOI: 10.1101/2023.01.25.525576.


Characterization of allergic inflammation in chronic uterine cervicitis.

Ma F, Liu J, Lv X, Liu H, Yang P, Ning Y Clin Exp Immunol. 2022; 207(1):44-52.

PMID: 35020843 PMC: 8802179. DOI: 10.1093/cei/uxab026.


References
1.
Amsel R, Totten P, Spiegel C, Chen K, Eschenbach D, Holmes K . Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983; 74(1):14-22. DOI: 10.1016/0002-9343(83)91112-9. View

2.
Westrom L . Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980; 138(7 Pt 2):880-92. DOI: 10.1016/0002-9378(80)91077-7. View

3.
Burnakis T, Hildebrandt N . Pelvic inflammatory disease: a review with emphasis on antimicrobial therapy. Rev Infect Dis. 1986; 8(1):86-116. DOI: 10.1093/clinids/8.1.86. View

4.
Ness R, Soper D, Peipert J, Sondheimer S, Holley R, Sweet R . Design of the PID Evaluation and Clinical Health (PEACH) Study. Control Clin Trials. 1998; 19(5):499-514. DOI: 10.1016/s0197-2456(98)00022-1. View

5.
Peipert J, Montagno A, Cooper A, Sung C . Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol. 1997; 177(5):1184-7. DOI: 10.1016/s0002-9378(97)70038-3. View